Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Peripheral Blood Stem Cells vs Bone Marrow for Matched Sibling Transplant in AML and ALL in First Remission.

Mark Kirschbaum, MD, M. O’Donnell, MD, R. Spielberger, MD, R. Bhatia, MD, V. Pullarkat, MD, A. S. Stein, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, J. Land, RN, C. Sarkodee-Adoo, MD, D. Snyder, MD, S. J. Forman, MD.

Blood (2004) 104 (11): 3321.

https://doi.org/10.1182/blood.V104.11.3321.3321

Published: 2004

Journal Articles

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

Anthony Selwyn Stein, MD, M. O’Donnell, MD, P. Parker, MD, R. Spielberger, MD, A. Nademanee, MD, R. Bhatia, MD, D. S. Snyder, MD, M. Kirschbaum, MD, V. Pullarkat, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, C. Sarkodee-Adoo, MD, M. Slovak, MD, N. Vora, MD, J. Land, RN, A. Dagis, J. Palmer, S. J. Forman, MD

Blood (2004) 104 (11): 1870.

https://doi.org/10.1182/blood.V104.11.1870.1870

Published: 2004

Journal Articles

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients

CM Verfaillie, R Bhatia, W Miller, F Mortari, V Roy, S Burger, J McCullough, K Stieglbauer, G Dewald, S Heimfeld, JS Miller, PB McGlave

Blood (1996) 87 (11): 4770–4779.

https://doi.org/10.1182/blood.V87.11.4770.bloodjournal87114770

Published: 1996

Journal Articles

Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia

R Bhatia, JB McCarthy, CM Verfaillie

Blood (1996) 87 (9): 3883–3891.

https://doi.org/10.1182/blood.V87.9.3883.bloodjournal8793883

Published: 1996

Journal Articles

Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages

R Bhatia, PB McGlave, GW Dewald, BR Blazar, CM Verfaillie

Blood (1995) 85 (12): 3636–3645.

https://doi.org/10.1182/blood.V85.12.3636.bloodjournal85123636

Published: 1995

NARROW

Peripheral Blood Stem Cells vs Bone Marrow for Matched Sibling Transplant in AML and ALL in First Remission.

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients

Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia

Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages

Email alerts

ASH Publications

American Society of Hematology

Peripheral Blood Stem Cells vs Bone Marrow for Matched Sibling Transplant in AML and ALL in First Remission.

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients

Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia

Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only